(Q37355727)

English

Potential new drug targets for osteoporosis

scientific article published on January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

Potential new drug targets for osteoporosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

0 references

author name string

Chad Deal

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Nature Clinical Practice Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

20-27

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

https://scigraph.springernature.com/pub.10.1038/ncprheum0977

0 references

Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of bone mass by Wnt signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Building bone to reverse osteoporosis and repair fractures

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disassociation of bone resorption and formation by GLP-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone morphogenetic proteins, their antagonists, and the skeleton

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo analysis of Wnt signaling in bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Denosumab: RANKL inhibition in the management of bone loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mineral density in sclerosteosis; affected individuals and gene carriers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biology of osteocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severely suppressed bone turnover: a potential complication of alendronate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emerging roles of cysteine cathepsins in disease and their potential as drug targets.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19098925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NCPRHEUM0977

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37355727&oldid=2102532230"